We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SEQUENT.NSE

Price
209.68
Stock movement up
+3.76 (1.83%)
Company name
Sequent Scientific Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
52.95B
Ent value
61.41B
Price/Sales
3.19
Price/Book
6.54
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
126.65
Forward P/E
-
PEG
-
EPS growth
-21.49%
1 year return
13.68%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

SEQUENT.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E126.65
Price to OCF41.28
Price to FCF72.47
Price to EBITDA33.37
EV to EBITDA38.71

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales3.19
Price to Book6.54
EV to Sales3.70

FINANCIALS

Per share

Per share data
Current share count252.54M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash707.70M
Net receivables4.23B
Total current assets9.61B
Goodwill2.75B
Intangible assets557.20M
Property, plant and equipment3.02B
Total assets17.26B
Accounts payable2.27B
Short/Current long term debt0.00
Total current liabilities5.04B
Total liabilities9.17B
Shareholder's equity8.09B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Stock price data
Open206.70
Daily high210.98
Daily low205.54
Daily Volume958K
All-time high323.60
1y analyst estimate133.50
Beta1.00
EPS (TTM)-
Dividend per share0.00
Ex-div date8 Sep 2021
Next earnings date9 Feb 2026

Downside potential

Downside potential data
SEQUENT.NSES&P500
Current price drop from All-time high-35.20%-1.08%
Highest price drop-60.85%-19.00%
Date of highest drop7 Apr 20258 Apr 2025
Avg drop from high-43.61%-2.64%
Avg time to new high-6 days
Max time to new high298 days89 days
COMPANY DETAILS
SEQUENT.NSE (Sequent Scientific Limited) company logo
Marketcap
52.95B
Marketcap category
Large-cap
Description
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Employees
1244
Website
https://www.sequent.in
Investor relations
-
SEC filings
SEQUENT.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved